Air Products & Chemicals, Inc.
APDNYSECIK 2969Basic Materials / Chemicalsfiscal year ends September73 quarters since 2008
Latest quarter Q3 FY2026, filed July 30, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of July 30, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed July 30, 2026.
| Millions of dollars | Q3 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q2 FY2026ended Mar 31, 2026filed Apr 30, 2026 | Q1 FY2026ended Dec 31, 2025filed Jan 30, 2026 | Q4 FY2025ended Sep 30, 2025filed Nov 20, 2025 | Q3 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q2 FY2025ended Mar 31, 2025filed May 1, 2025 | Q1 FY2025ended Dec 31, 2024filed Feb 6, 2025 | Q4 FY2024ended Sep 30, 2024filed Nov 21, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,161 | 3,172 | 3,103 | 3,167 | 3,023 | 2,916 | 2,932 | 3,188 | +4.6% |
| Cost of revenue | 2,125 | 2,184 | 2,108 | 2,146 | 2,040 | 2,054 | 2,017 | 2,104 | +4.2% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | 22 | 22 | 20 | 27 | 24 | 23 | 22 | 22 | −10.8% |
| Selling, general and administrative | 219 | 227 | 229 | 219 | 223 | 222 | 242 | 228 | −1.6% |
| Operating income | (2,097) | 753 | 735 | 17 | 791 | (2,328) | 644 | 2,424 | −365.3% |
| Other income (expense) | 4 | 1 | (1) | (12) | (6) | (19) | 39 | (48) | +160.0% |
| Pretax income | (1,938) | 884 | 851 | 121 | 891 | (2,243) | 791 | 2,503 | −317.5% |
| Income tax | (515) | 159 | 159 | 111 | 160 | (506) | 141 | 538 | −422.9% |
| Net income | (1,441) | 710 | 678 | 5 | 714 | (1,731) | 617 | 1,950 | −301.8% |
| Diluted EPS ($) | (6.47) | 3.19 | 3.04 | — | 3.20 | (7.77) | 2.77 | — | −302.2% |
| Diluted shares (millions) | 223 | 223 | 223 | — | 223 | 223 | 223 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed July 30, 2026.
| Millions of dollars | Q3 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q2 FY2026ended Mar 31, 2026filed Apr 30, 2026 | Q1 FY2026ended Dec 31, 2025filed Jan 30, 2026 | Q4 FY2025ended Sep 30, 2025filed Nov 20, 2025 | Q3 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q2 FY2025ended Mar 31, 2025filed May 1, 2025 | Q1 FY2025ended Dec 31, 2024filed Feb 6, 2025 | Q4 FY2024ended Sep 30, 2024filed Nov 21, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 981 | 951 | 1,026 | 1,856 | 2,324 | 1,491 | 1,846 | 2,980 | −57.8% |
| Short-term investments | — | — | — | 0 | 0 | 111 | 118 | 5 | — |
| Total current assets | 4,964 | 5,013 | 5,103 | 5,826 | 6,148 | 5,188 | 5,352 | 6,363 | −19.3% |
| Total assets | 40,446 | 41,645 | 41,241 | 41,060 | 41,659 | 38,873 | 40,017 | 39,575 | −2.9% |
| Total current liabilities | 4,575 | 3,513 | 3,498 | 4,219 | 4,760 | 5,211 | 4,809 | 4,180 | −3.9% |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Total liabilities | 23,849 | 23,495 | 23,404 | 23,710 | 23,891 | 22,093 | 21,279 | 20,901 | −0.2% |
| Stockholders’ equity | 13,884 | 15,650 | 15,411 | 15,025 | 15,538 | 14,703 | 16,692 | 17,037 | −10.6% |
| Shares outstanding (millions) | 223 | 223 | 223 | 223 | 223 | 223 | 222 | 222 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed July 30, 2026.
| Millions of dollars | Q3 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q2 FY2026ended Mar 31, 2026filed Apr 30, 2026 | Q1 FY2026ended Dec 31, 2025filed Jan 30, 2026 | Q4 FY2025ended Sep 30, 2025filed Nov 20, 2025 | Q3 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q2 FY2025ended Mar 31, 2025filed May 1, 2025 | Q1 FY2025ended Dec 31, 2024filed Feb 6, 2025 | Q4 FY2024ended Sep 30, 2024filed Nov 21, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,305 | 1,104 | 901 | — | 856 | 328 | 812 | — | +52.5% |
| Capital expenditures | 996 | 1,108 | 1,251 | 1,518 | 1,496 | 1,892 | 2,118 | 2,075 | −33.4% |
| Free cash flow (CFO − capex) | 310 | (4) | (350) | — | (640) | (1,563) | (1,306) | — | +148.4% |
| Depreciation and amortization | 385 | 375 | 371 | 413 | 401 | 384 | 367 | 381 | −3.9% |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Dividends paid | 403 | 399 | 398 | 398 | 398 | 394 | 394 | 394 | +1.2% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed November 20, 2025.
Income statement
| Millions of dollars | FY2025ended Sep 30, 2025filed Nov 20, 2025 | FY2024ended Sep 30, 2024filed Nov 21, 2024 | FY2023ended Sep 30, 2023filed Nov 16, 2023 | FY2022ended Sep 30, 2022filed Nov 22, 2022 | FY2021ended Sep 30, 2021filed Nov 18, 2021 | FY2020ended Sep 30, 2020filed Nov 19, 2020 | FY2019ended Sep 30, 2019filed Nov 26, 2019 | FY2018ended Sep 30, 2018filed Nov 20, 2018 | FY2017ended Sep 30, 2017filed Nov 16, 2017 | FY2016ended Sep 30, 2016filed Nov 21, 2016 | FY2015ended Sep 30, 2015filed Nov 24, 2015 | FY2014ended Sep 30, 2014filed Nov 24, 2014 | FY2013ended Sep 30, 2013filed Nov 26, 2013 | FY2012ended Sep 30, 2012filed Nov 20, 2012 | FY2011ended Sep 30, 2011filed Nov 22, 2011 | FY2010ended Sep 30, 2010filed Nov 23, 2010 | FY2009ended Sep 30, 2009filed Nov 25, 2009 | FY2008ended Sep 30, 2008filed Jul 24, 2009 | FY2007ended Sep 30, 2007filed Jul 24, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12,037 | 12,101 | 12,600 | 12,699 | 10,323 | 8,856 | 8,919 | 8,930 | 8,188 | 7,504 | 7,824 | 10,439 | 10,180 | 9,612 | 9,674 | 8,616 | 8,256 | 10,415 | 9,148 |
| Cost of revenue | 8,256 | 8,169 | 8,833 | 9,339 | 7,186 | 5,858 | 5,976 | 6,190 | 5,752 | 5,177 | 5,598 | 7,630 | 7,472 | 7,052 | 7,098 | 6,289 | 6,042 | 7,693 | 6,699 |
| Gross profit | — | — | — | — | — | 2,998 | 2,914 | 2,741 | 2,436 | 2,327 | 2,956 | 2,804 | 2,708 | 2,560 | 2,575 | 2,523 | 2,214 | — | — |
| Research and development | 96 | 100 | 106 | 103 | 94 | 84 | 73 | 65 | 58 | 72 | 76 | 140 | 134 | 126 | 119 | 115 | 116 | 131 | 129 |
| Selling, general and administrative | 906 | 942 | 957 | 901 | 828 | 776 | 750 | 761 | 714 | 684 | 773 | 1,055 | 1,066 | 947 | 942 | 887 | 943 | 1,090 | 1,000 |
| Operating income | (877) | 4,466 | 2,495 | 2,339 | 2,281 | 2,238 | 2,144 | 1,966 | 1,440 | 1,535 | 1,233 | 1,339 | 1,324 | 1,282 | 1,508 | 1,268 | 846 | 1,496 | 1,376 |
| Other income (expense) | 3 | (74) | (39) | 62 | 74 | 31 | 67 | 5 | 17 | (5) | 0 | — | — | — | — | — | — | — | — |
| Pretax income | (441) | 4,821 | 2,882 | 2,755 | 2,507 | 2,424 | 2,290 | 2,015 | 1,416 | 1,555 | 1,266 | 1,365 | 1,350 | 1,313 | 1,547 | 1,273 | 837 | — | — |
| Income tax | (94) | 945 | 551 | 501 | 463 | 478 | 480 | 524 | 261 | 433 | 300 | 369 | 308 | 287 | 375 | 306 | 185 | 365 | 287 |
| Net income | (394) | 3,828 | 2,300 | 2,256 | 2,099 | 1,887 | 1,760 | 1,498 | 3,000 | 631 | 1,278 | 992 | 994 | 1,167 | 1,224 | 1,029 | 631 | 910 | 1,036 |
| Diluted EPS ($) | (1.77) | 17.18 | 10.33 | 10.14 | 9.43 | 8.49 | 7.94 | 6.78 | 13.65 | 2.89 | 5.88 | 4.61 | 4.68 | 5.44 | 5.63 | 4.74 | 2.96 | 4.15 | 4.64 |
| Diluted shares (millions) | 223 | 223 | 223 | 223 | 223 | 222 | 222 | 221 | 220 | 218 | 217 | 215 | 212 | 215 | 218 | 217 | 214 | 219 | 223 |
Balance sheet
| Millions of dollars | FY2025ended Sep 30, 2025filed Nov 20, 2025 | FY2024ended Sep 30, 2024filed Nov 21, 2024 | FY2023ended Sep 30, 2023filed Nov 16, 2023 | FY2022ended Sep 30, 2022filed Nov 22, 2022 | FY2021ended Sep 30, 2021filed Nov 18, 2021 | FY2020ended Sep 30, 2020filed Nov 19, 2020 | FY2019ended Sep 30, 2019filed Nov 26, 2019 | FY2018ended Sep 30, 2018filed Nov 20, 2018 | FY2017ended Sep 30, 2017filed Nov 16, 2017 | FY2016ended Sep 30, 2016filed Nov 21, 2016 | FY2015ended Sep 30, 2015filed Nov 24, 2015 | FY2014ended Sep 30, 2014filed Nov 24, 2014 | FY2013ended Sep 30, 2013filed Nov 26, 2013 | FY2012ended Sep 30, 2012filed Nov 20, 2012 | FY2011ended Sep 30, 2011filed Nov 22, 2011 | FY2010ended Sep 30, 2010filed Nov 23, 2010 | FY2009ended Sep 30, 2009filed Nov 25, 2009 | FY2008ended Sep 30, 2008filed Jul 24, 2009 | FY2007ended Sep 30, 2007filed Jul 24, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,856 | 2,980 | 1,617 | 2,711 | 4,469 | 5,253 | 2,249 | 2,791 | 3,274 | 1,293 | 183 | 337 | 450 | 454 | 421 | 374 | 488 | 104 | 41 |
| Short-term investments | 0 | 5 | 332 | 591 | 1,332 | 1,105 | 166 | 185 | 404 | 0 | — | — | — | — | — | — | — | — | — |
| Total current assets | 5,826 | 6,363 | 5,201 | 6,283 | 8,376 | 8,685 | 4,618 | 5,108 | 5,877 | 4,317 | 2,794 | 3,295 | 3,439 | 3,416 | 3,190 | 3,034 | 2,998 | 2,848 | — |
| Total assets | 41,060 | 39,575 | 32,003 | 27,193 | 26,859 | 25,169 | 18,943 | 19,205 | 18,467 | 18,029 | 17,317 | 17,668 | 17,850 | 16,942 | 14,291 | 13,506 | 13,029 | 12,571 | — |
| Total current liabilities | 4,219 | 4,180 | 3,896 | 3,466 | 2,799 | 2,417 | 1,821 | 2,365 | 2,489 | 3,283 | 3,644 | 2,963 | 3,228 | 2,690 | 2,342 | 2,244 | 2,504 | 2,212 | — |
| Long-term debt | — | — | — | — | — | — | — | — | — | 3,910 | 3,949 | 4,825 | 5,056 | 4,584 | 3,928 | 3,660 | 3,716 | 3,515 | — |
| Total liabilities | 23,710 | 20,901 | 16,342 | 13,490 | 12,771 | 12,725 | 7,555 | 8,028 | 8,282 | 10,815 | 9,953 | 9,971 | 10,275 | 9,926 | 8,352 | 7,808 | 8,099 | 7,404 | — |
| Stockholders’ equity | 15,025 | 17,037 | 14,313 | 13,144 | 13,540 | 12,080 | 11,054 | 10,858 | 10,086 | 7,080 | 7,249 | 7,366 | 7,042 | 6,477 | 5,796 | 5,547 | 4,792 | 5,031 | 5,496 |
| Shares outstanding (millions) | 223 | 222 | 222 | 222 | 221 | 221 | 220 | 220 | 219 | 217 | 215 | 214 | 211 | 213 | 210 | 214 | 212 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Sep 30, 2025filed Nov 20, 2025 | FY2024ended Sep 30, 2024filed Nov 21, 2024 | FY2023ended Sep 30, 2023filed Nov 16, 2023 | FY2022ended Sep 30, 2022filed Nov 22, 2022 | FY2021ended Sep 30, 2021filed Nov 18, 2021 | FY2020ended Sep 30, 2020filed Nov 19, 2020 | FY2019ended Sep 30, 2019filed Nov 26, 2019 | FY2018ended Sep 30, 2018filed Nov 20, 2018 | FY2017ended Sep 30, 2017filed Nov 16, 2017 | FY2016ended Sep 30, 2016filed Nov 21, 2016 | FY2015ended Sep 30, 2015filed Nov 24, 2015 | FY2014ended Sep 30, 2014filed Nov 24, 2014 | FY2013ended Sep 30, 2013filed Nov 26, 2013 | FY2012ended Sep 30, 2012filed Nov 20, 2012 | FY2011ended Sep 30, 2011filed Nov 22, 2011 | FY2010ended Sep 30, 2010filed Nov 23, 2010 | FY2009ended Sep 30, 2009filed Nov 25, 2009 | FY2008ended Sep 30, 2008filed Jul 24, 2009 | FY2007ended Sep 30, 2007filed Jul 24, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,753 | 1,522 | 1,329 | 1,659 | 1,500 |
| Capital expenditures | 7,023 | 6,797 | 4,626 | 2,927 | 2,464 | 2,509 | 1,990 | 1,568 | 1,040 | 908 | 1,162 | 1,363 | 1,524 | 1,521 | 1,309 | 989 | 1,179 | 1,085 | 1,013 |
| Free cash flow (CFO − capex) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 444 | 534 | 150 | 574 | 487 |
| Depreciation and amortization | 1,564 | 1,451 | 1,358 | 1,338 | 1,321 | 1,185 | 1,083 | 971 | 866 | 855 | 859 | 957 | 907 | 841 | 834 | 827 | 840 | 869 | 790 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 462 | 53 | 649 | 0 | 0 | 793 | 575 |
| Dividends paid | 1,584 | 1,565 | 1,497 | 1,383 | 1,257 | 1,104 | 994 | 898 | 788 | 721 | 678 | 628 | 566 | 515 | 457 | 399 | 373 | 349 | 312 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Pellicciotti William J Jr | Principal Accounting Officer | tax withholding | 338 | $307.12 | $104K | 3,769 | Oct 29, 2026 |
| Aug 18, 2026 | Lepore Matthew | EVP & General Counsel | tax withholding | 418 | $303.62 | $127K | 5,160 | Sep 11, 2026 |
| May 1, 2026 | Schaeffer Melissa N. | Exec Vice President and CFO | open-market sale | 2,714 | $303.76 | $824K | 14,212 | May 4, 2026 |
| Feb 12, 2026 | Mantle Ridge LP+2 more | Director | open-market saleindirect | 70,175 | $284.21 | $20M | 93,499 | Feb 13, 2026 |
| Feb 12, 2026 | Mantle Ridge LP+2 more | Director | otherindirect | 4M | $0.00 | — | 163,674 | Feb 13, 2026 |
| Feb 12, 2026 | Mantle Ridge LP+2 more | Director | giftindirect | 1,759 | $0.00 | — | 91,740 | Feb 13, 2026 |
| Dec 3, 2025 | Lefevere Kurt | President, Asia | tax withholding | 64 | $261.28 | $17K | 3,415 | Dec 15, 2025 |
| Dec 3, 2025 | Menezes Eduardo F | Chief Executive Officer | otherindirect | 38 | $0.00 | — | 38 | Dec 3, 2025 |
| Dec 3, 2025 | Pellicciotti William J Jr | Principal Accounting Officer | otherindirect | 116 | $0.00 | — | 143 | Dec 3, 2025 |
| Dec 3, 2025 | Lefevere Kurt | President, Asia | tax withholding | 65 | $261.28 | $17K | 3,414 | Dec 3, 2025 |
| Dec 3, 2025 | Lefevere Kurt | President, Asia | tax withholding | 80 | $261.28 | $21K | 3,334 | Dec 3, 2025 |
| Dec 3, 2025 | Lefevere Kurt | President, Asia | award | 144 | $0.00 | — | 3,479 | Dec 3, 2025 |
| Dec 3, 2025 | Maione Francesco | President, Americas | otherindirect | 11 | $0.00 | — | 11 | Dec 3, 2025 |
| Dec 3, 2025 | Schaeffer Melissa N. | Exec Vice President and CFO | otherindirect | 44 | $0.00 | — | 455 | Dec 3, 2025 |
| Dec 2, 2025 | Maione Francesco | President, Americas | award | 873 | $0.00 | — | 18,187 | Dec 3, 2025 |
| Dec 2, 2025 | Maione Francesco | President, Americas | tax withholding | 283 | $261.28 | $74K | 17,904 | Dec 3, 2025 |
| Dec 2, 2025 | Maione Francesco | President, Americas | tax withholding | 380 | $261.28 | $99K | 17,524 | Dec 3, 2025 |
| Dec 2, 2025 | Bols Ivo | President, Europe & Africa | award | 873 | $0.00 | — | 12,834 | Dec 3, 2025 |
| Dec 2, 2025 | Schaeffer Melissa N. | Exec Vice President and CFO | award | 3,205 | $0.00 | — | 19,037 | Dec 3, 2025 |
| Dec 2, 2025 | Schaeffer Melissa N. | Exec Vice President and CFO | tax withholding | 1,402 | $261.28 | $366K | 16,926 | Dec 3, 2025 |
| Dec 2, 2025 | Schaeffer Melissa N. | Exec Vice President and CFO | tax withholding | 709 | $261.28 | $185K | 18,328 | Dec 3, 2025 |
| Dec 1, 2025 | Menezes Eduardo F | Chief Executive Officer | award | 17,376 | $0.00 | — | 30,724 | Dec 3, 2025 |
| Dec 1, 2025 | Lepore Matthew | EVP & General Counsel | award | 2,107 | $0.00 | — | 5,578 | Dec 3, 2025 |
| Dec 1, 2025 | Pellicciotti William J Jr | Principal Accounting Officer | award | 850 | $0.00 | — | 4,107 | Dec 3, 2025 |
| Dec 1, 2025 | Lefevere Kurt | President, Asia | award | 1,873 | $0.00 | — | 3,335 | Dec 3, 2025 |
Full insider history for Air Products & Chemicals, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Sources
Fiscal year ends in month 9; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- AIR PRODUCTS AND CHEMICALS, INC., CIK 2969 on EDGAR
- Extract generated
- August 27, 2026
- Withheld
- 5 line-years whose four quarters do not sum to the filed year: operating income FY2010, revenue FY2010, income tax FY2015, operating income FY2015, revenue FY2015
- Repaired
- 1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2018
XBRL concepts behind each line
Income statement
Revenues, SalesRevenueNetCostOfGoodsAndServicesSoldGrossProfitResearchAndDevelopmentExpenseSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueShortTermInvestmentsAssetsCurrentAssetsLiabilitiesCurrentLongTermDebtNoncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated August 27, 2026.
- JSON file
/data/financials/APD.json